Characteristics of circulatory failure after out-of-hospital cardiac arrest: a prospective cohort study

Halvor Langeland1,2, Daniel Bergum3, Magnus Løberg4,5

  • 1Department of Anesthesiology and Intensive Care Medicine, St. Olav's University Hospital, Trondheim, Norway halvor.langeland@ntnu.no.

Open Heart
|January 20, 2022
PubMed

Insights

Circulatory failure after cardiac arrest is primarily due to heart dysfunction, not inflammation. Heart failure biomarkers, not inflammatory ones, predicted the need for longer circulatory support in patients.

Area of Science:

  • Cardiology
  • Critical Care Medicine
  • Hemodynamics

Background:

  • Post-cardiac arrest syndrome (PCAS) involves circulatory failure, potentially from myocardial depression and vasodilation.
  • The roles of myocardial dysfunction and systemic inflammation in PCAS circulatory failure remain unclear.
  • Detailed macrocirculatory and microcirculatory assessments are needed for PCAS patients.

Purpose of the Study:

  • To investigate the macrocirculatory and microcirculatory failure in postcardiac arrest syndrome.
  • To differentiate the contributions of myocardial dysfunction and systemic inflammation to circulatory failure in PCAS.
  • To identify predictors of circulatory support duration in PCAS patients.

Main Methods:

  • Invasive monitoring of circulatory variables in 42 comatose OHCA patients from admission to day 5.
  • Measurement of cardiac power output (CPO), stroke work (SW), aortic elastance, microcirculatory metabolism, and biomarkers.
  • Survival analysis and Cox regression to assess time to norepinephrine discontinuation and fluid balance, stratified by biomarkers.

Main Results:

  • Cardiac power output, stroke work, and oxygen delivery increased within 48 hours.
  • Macrocirculatory homeostasis was gradually restored, with decreasing norepinephrine need.
  • Higher pro-brain natriuretic peptide levels predicted longer norepinephrine use; inflammatory markers did not.
  • Microcirculatory distress markers normalized within 24 hours.

Conclusions:

  • Circulatory failure in PCAS is initially characterized by reduced cardiac function but resolves within 48 hours.
  • Biomarkers of acute heart failure, not inflammation, predicted the duration of circulatory support.
  • Findings suggest early, resolving cardiac dysfunction rather than late vasodilation is key in PCAS circulatory failure.
Abstract

Related Concept Videos

Heart Failure I: Introduction01:27

Heart Failure I: Introduction

Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
114
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
1.9K
Cardiopulmonary Resuscitation I: Adult01:21

Cardiopulmonary Resuscitation I: Adult

Cardiopulmonary resuscitation, or CPR, is a life-saving emergency procedure performed when a person's heart has stopped beating or they are no longer breathing. The foundation of CPR is Basic Life Support (BLS), which focuses on the early recognition of cardiac arrest, the immediate start of high-quality chest compressions, and the timely use of an automated external defibrillator (AED).Assessing Responsiveness and Checking the Carotid PulseWhen approaching an unresponsive person, first ensure...
153
Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
389
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
59
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
59